Related Experiment Video
Updated: Jun 27, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
CRISPR Advancements for Human Health
Daniel J Davis1, Sai Goutham Reddy Yeddula2
1Assistant Director - Animal Modeling Core; Assistant Research Professor - Department of Veterinary Pathobiology; and Comparative Medicine Program Faculty, University of Missouri - Columbia, Columbia, Missouri.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing technology offers revolutionary potential in medicine. Ongoing research is crucial to optimize CRISPR delivery, efficacy, and safety for clinical applications.
Area of Science:
- Biomedical Research
- Gene Editing Technology
- Clinical Medicine
Background:
- CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a transformative gene editing tool.
- It enables precise modification of the genetic code across diverse organisms.
- This technology is rapidly advancing biomedical research and clinical applications.
Purpose of the Study:
- To provide a comprehensive review of the CRISPR system and its mechanisms.
- To highlight current and potential clinical applications of CRISPR technology.
- To discuss challenges hindering the clinical translation of CRISPR.
Main Methods:
- Review of existing literature on CRISPR gene editing.
- Explanation of the CRISPR system's molecular mechanisms.
- Analysis of CRISPR's application in various medical fields.
Main Results:
- CRISPR technology allows for rewriting genetic material.
- Potential applications span genetic disorders, infectious diseases, cancer, and regenerative medicine.
- Key challenges include optimizing delivery, efficacy, and safety for clinical use.
Conclusions:
- CRISPR gene editing holds significant promise for advancing precision medicine.
- Further research is essential to overcome current limitations.
- Successful clinical translation requires enhanced delivery, efficacy, and safety protocols.
More Related Videos
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
10:07Construction of Homozygous Mutants of Migratory Locust Using CRISPR/Cas9 Technology
Published on: March 16, 2022
Related Concept Videos
CRISPR
What is Genetic Engineering?
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination